跳至主要内容
临床试验/NCT04580524
NCT04580524撤回不适用

Poly-4-hydroxybutyrate Mesh Versus Current Care of Complex Open Ventral Hernias: A Multi-Center Randomized Controlled Trial

The University of Texas Health Science Center, Houston4 个研究点 分布在 1 个国家开始时间: 2021年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
4
主要终点
Major complication free

研究概览

简要总结

The purpose of this study is to compare clinical and patient centered outcomes of biosynthetic poly-4-hydroybutyrate meshes versus current care (synthetic polypropylene mesh or suture) for complex ventral hernia repair. The primary outcome for this study will be patients who are major complication free at 2 years postoperative. This will be a composite of hernia recurrence, reoperation, chronic wound complication, or death. Secondary outcomes include: surgical site occurences such as surgical site infection, seroma, hematoma and skin dehiscence within 90 days postoperative, emergency room visits withing 90 days postoperative, days in hospital up to 90 days postoperative, abdominal pain, and change in patient centered outcomes measured through the modified activities assessment scale (mAAS).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients (18 years or older) with a complex ventral hernia scheduled for repair

排除标准

  • Patients likely to die within 3 years (cirrhosis, terminal cancer, surgeon judgement)
  • Unlikely to follow-up (live out of state, unable to be reached by phone or email)
  • Non-English and non-Spanish speakers
  • Pregnant or breast-feeding patients
  • Allergies/hypersensitivities to tetracycline hydrochloride and kanamycin sulfate

结局指标

主要结局

Major complication free

时间窗: 2 years post-operative

A composite of hernia recurrence, reoperation, chronic wound complication, or death

次要结局

  • Surgical site occurrences(90 days post-operative)
  • Hospital duration(90 days post-operative)
  • Post-operative abdominal pain(Day of consent and post-operatively at 1 month, 1 year and 2 years)
  • Clavien-Dindo complication grade(90 days post-operative)
  • Emergency room visits(90 days post-operative)
  • Cost Analysis(2 years)
  • Patient centered outcomes(Day of consent and post-operatively at 1 month, 1 year and 2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Julie Holihan

Assistant Professor of Surgery-Clinical

The University of Texas Health Science Center, Houston

研究点 (4)

Loading locations...

相似试验